Zenas Biopharma

ZBIO · NASDAQ

$28.18+$1.47 (+5.50%)TodayMarket closed ·
Prev close $26.71

Who owns ZBIO

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 59.9% of ZBIO’s shares.

  • Fidelity Management & Research Company LLC11.8%
  • SR One Capital Management, LP8.0%
  • InnoCare Pharma Inc.7.9%
  • New Enterprise Associates (NEA)6.4%
  • Next 6 largest institutions25.8%
  • All other shareholders40.1%
Top institutional holders of ZBIO
HolderShares% of shares
Fidelity Management & Research Company LLC7.47M11.83%
SR One Capital Management, LP5.04M7.98%
InnoCare Pharma Inc.5.00M7.92%
New Enterprise Associates (NEA)4.02M6.37%
Enavate Sciences GP, LLC3.25M5.14%
Federated Hermes Global Investment Management Corp.3.12M4.94%
Longitude Capital Management Co., LLC2.61M4.13%
Capital International Investors2.50M3.96%
Polar Capital LLP2.41M3.82%
BlackRock Institutional Trust Company, N.A.2.41M3.82%

Largest mutual fund holders

Top mutual fund holders of ZBIO
HolderShares% of shares
American Funds SMALLCAP World Fund2.43M3.86%
Polar Capital Biotechnology Fund2.29M3.62%
State Street SPDR S&P Biotech ETF1.42M2.26%
Federated Hermes Kaufmann Fund1.33M2.11%
Fidelity Select Health Care Portfolio1.08M1.71%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $2.08M (3 trades) of ZBIO on the open market, with no sales.

Latest ZBIO insider transactions
InsiderTypeSharesValue
Oliger Christy J.Award37.00K—
ORLOFF JOHN JAward18.50K—
Nunn Jason RaleighAward18.50K—
Allen Patricia LAward18.50K—
Farmer Joseph LAward175.00K—
ENRIGHT PATRICK GAward18.50K—
MOULDER LEON O JRAward500.00K—
MOULDER LEON O JRBuy60.00K$1.01M
MOULDER LEON O JRBuy35.00K$616.70K
MOULDER LEON O JRBuy25.00K$450.50K

Short interest

Settled Sep 30, 2026

Shares short
11.94M
Days to cover
15.48
% of shares outstanding
18.92%
Average daily volume
771.65K
Change since last report
+0.6%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.